Study Title | Application of innovative molecular profiling techniques to improve diagnosis of paediatric central nervous system tumours and develop an accredited Australasian molecular profiling service |
---|---|
Protocol ID | ACCT009 (AIM BRAIN PROject) |
Disease (Sub Disease) | Central Nervous System Tumours |
Diagnosis Stage | New Diagnosis Relapse |
Location | NSW / QLD / VIC / WA / SA / NZ / TAS |
Sponsor | Australian and New Zealand Children's Haematology Oncology Group |
Links | https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374062&isReview=true |
Trial Status | Open |
Trial Open Date | 27/03/2018 |
Sites | The Children's Hospital at Westmead / John Hunter Children's Hospital / Monash Children's Hospital / Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital / Royal Children's Hospital / Women's & Children's Hospital / Royal Hobart Hospital / Christchurch Hospital / Starship Hospital |
Study Type | Diagnosis |
Phase | Not applicable |
Age Eligibility | up to 21 years |
ANZCTR | ACTRN12618000006246 |